A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology

Oncogene. 2006 May 25;25(22):3093-103. doi: 10.1038/sj.onc.1209636.

Abstract

MLL-AF4 fusion is the most common consequence of chromosomal translocations in infant leukaemia and is associated with a poor prognosis. MLL-AF4 is thought to be required in haematopoietic stem cells to elicit leukaemia and may be involved in tumour phenotype specification as it is only found in B-cell tumours in humans. We have employed the invertor conditional technology to create a model of MLL-AF4, in which a floxed AF4 cDNA was knocked into Mll in the opposite orientation for transcription. Cell-specific Cre expression was used to generate Mll-AF4 expression. The mice develop exclusively B-cell lineage neoplasias, whether the Cre gene was controlled by B- or T-cell promoters, but of a more mature phenotype than normally observed in childhood leukaemia. These findings show that the MLL-AF4 fusion protein does not have a mandatory role in multi-potent haematopoietic stem cells to cause cancer and indicates that MLL-AF4 has an instructive function in the phenotype of the tumour.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / metabolism
  • B-Lymphocytes / pathology*
  • Cell Lineage*
  • Cell Transformation, Neoplastic*
  • Female
  • Genes, Lethal
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / physiology
  • Humans
  • Integrases / metabolism
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / pathology*
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Myeloid-Lymphoid Leukemia Protein / physiology*
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / physiology*
  • Phenotype
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / pathology

Substances

  • Homeodomain Proteins
  • MLL-AF4 fusion protein, human
  • Oncogene Proteins, Fusion
  • RAG-1 protein
  • Myeloid-Lymphoid Leukemia Protein
  • Cre recombinase
  • Integrases